PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
21977017-6	2011	Phox2b(+/-) pups also showed lower oxygen consumption (VO(2)) in the cold, reflecting reduced thermogenesis and a lower body temperature.	vo(2)	55-60	paired-like homeobox 2b	Mus musculus	0-6
22739069-7	2012	In multivariate analysis HbA1c negatively correlated with VO(2).	vo(2)	58-63	hemoglobin subunit alpha 1	Homo sapiens	25-29
22889317-6	2012	RESULTS: Fat free mass adjusted insulin sensitivity was significantly correlated to VO(2)peak (r = 0.43, p = 0.007).	vo(2)	84-89	insulin	Homo sapiens	32-39
21790328-5	2011	Values at peak exercise for Vo(2) at morning and afternoon testing were 3.20 +- 0.49 and 3.24 +- 0.55 L min(-1), respectively, for heart rate 190 +- 11 and 188 +- 15 bpm, and for cardiac output 19.5 +- 2.8 and 19.8 +- 3.5 L min(-1).	vo(2)	28-33	CD59 molecule (CD59 blood group)	Homo sapiens	104-110
20049481-4	2010	The bias +/-95% limits of agreement (LOA) for VO(2) was 393 +/- 507 ml min(-1) for the submaximal constant work test at 100 W and 495 +/- 727 ml min(-1) for VO(2max).	vo(2)	46-51	CD59 molecule (CD59 blood group)	Homo sapiens	71-77
21414676-8	2011	Regression analysis demonstrated that perceived adequacy and physical activity were significant mediators in the relationship between p-DCD and VO(2)peak (R-squared=24.3%).	vo(2)	144-149	dermcidin	Homo sapiens	136-139
20493790-5	2010	The balance between VO(2) and DO(2) is given by fractional oxygen extraction (FOE=VO(2)/DO(2)).	vo(2)	20-25	WAPL cohesin release factor	Homo sapiens	78-81
20049481-4	2010	The bias +/-95% limits of agreement (LOA) for VO(2) was 393 +/- 507 ml min(-1) for the submaximal constant work test at 100 W and 495 +/- 727 ml min(-1) for VO(2max).	vo(2)	46-51	CD59 molecule (CD59 blood group)	Homo sapiens	145-151
20049481-5	2010	At maximal intensity, cardiopulmonary responses measured with the Aquatrainer system were significantly lower for: VO(2) (2,799 +/- 751 vs. 3,294 +/- 821 ml min(-1), P < 0.0001), VCO(2) (3,426 +/- 836 vs. 3,641 +/- 946 ml min(-1), P = 0.012), VE (98 +/- 21 vs. 108 +/- 26 l min(-1), P = 0.0009) relative to facemask.	vo(2)	115-120	CD59 molecule (CD59 blood group)	Homo sapiens	157-163
20049481-5	2010	At maximal intensity, cardiopulmonary responses measured with the Aquatrainer system were significantly lower for: VO(2) (2,799 +/- 751 vs. 3,294 +/- 821 ml min(-1), P < 0.0001), VCO(2) (3,426 +/- 836 vs. 3,641 +/- 946 ml min(-1), P = 0.012), VE (98 +/- 21 vs. 108 +/- 26 l min(-1), P = 0.0009) relative to facemask.	vo(2)	115-120	CD59 molecule (CD59 blood group)	Homo sapiens	225-231
20049481-5	2010	At maximal intensity, cardiopulmonary responses measured with the Aquatrainer system were significantly lower for: VO(2) (2,799 +/- 751 vs. 3,294 +/- 821 ml min(-1), P < 0.0001), VCO(2) (3,426 +/- 836 vs. 3,641 +/- 946 ml min(-1), P = 0.012), VE (98 +/- 21 vs. 108 +/- 26 l min(-1), P = 0.0009) relative to facemask.	vo(2)	115-120	CD59 molecule (CD59 blood group)	Homo sapiens	225-231
18789116-8	2008	Based on these results, DHP-PMX should be introduced during the period when VO(2)I is still equal to or greater than 100 mL/min/m(2).	vo(2)	76-81	dihydropyrimidinase	Homo sapiens	24-27
18239561-8	2008	Elevated (P < 0.001) concentrations of IL-6 following moderate (50% VO(2)) and high (75% VO(2)) intensity acute exercise were observed in both groups; however, concentrations of TNF-alpha were unchanged in response to acute exercise (P = 0.584).	vo(2)	71-76	interleukin 6	Homo sapiens	42-46
18492778-4	2008	Stimulation of the TA muscle elicited large increases in Vo(2) (3- to 6-fold and 4- to 60-fold above resting levels in WTA and RTA, respectively).	vo(2)	57-62	MAS related GPR family member F	Homo sapiens	127-130
18492778-6	2008	During contractions, similar degrees of phosphorylation in RTA and WTA were evident as a function of Vo(2) for p38 and p42.	vo(2)	101-106	MAS related GPR family member F	Homo sapiens	59-62
18492778-7	2008	During increases in Vo(2) up to sixfold above rest, greater responses were observed in RTA than in WTA for AMPK and p44, whereas Akt activation was greater in WTA.	vo(2)	20-25	MAS related GPR family member F	Homo sapiens	87-90
18492778-7	2008	During increases in Vo(2) up to sixfold above rest, greater responses were observed in RTA than in WTA for AMPK and p44, whereas Akt activation was greater in WTA.	vo(2)	20-25	interferon induced protein 44	Homo sapiens	116-119
18492778-8	2008	In RTA, elevations in Vo(2) elicited increases in AMPK and p44 activation, whereas Akt, p38, and p42 were less sensitive to increments in Vo(2).	vo(2)	22-27	MAS related GPR family member F	Homo sapiens	3-6
18492778-8	2008	In RTA, elevations in Vo(2) elicited increases in AMPK and p44 activation, whereas Akt, p38, and p42 were less sensitive to increments in Vo(2).	vo(2)	22-27	interferon induced protein 44	Homo sapiens	59-62
17449423-10	2007	NT Pro BNP values exceeding 335 pg/ml showed 83% sensitivity and 76% specificity for detecting VO(2) values below 20 ml/kg/min (area under the curve [AUC] = 86%, p < 0.001).	vo(2)	95-100	natriuretic peptide B	Homo sapiens	7-10
17449423-11	2007	NT Pro BNP plasma levels exceeding 1,190 pg/ml showed 83% sensitivity and 86% specificity for detecting VO(2) of less than 14 ml/kg/min (AUC = 90%, p < 0.001).	vo(2)	104-109	natriuretic peptide B	Homo sapiens	7-10
17449423-12	2007	NT Pro BNP plasma levels exceeding 1,610 pg/ml showed 87% sensitivity and specificity 82% for detecting VO(2) of less than 10 ml/kg/min (AUC = 90%, p < 0.001).	vo(2)	104-109	natriuretic peptide B	Homo sapiens	7-10
12204502-6	2002	RESULTS: In patients with chronic HF, BNP levels correlated with oxygen uptake (VO(2)), both at anaerobic threshold (VO(2)AT: r = -0.54, p < 0.001) and peak exercise (peak VO(2): r = -0.56, p < 0.001).	vo(2)	80-85	natriuretic peptide B	Homo sapiens	38-41
15120815-9	2004	However, in patients with supra-median levels of BNP, independent predictors of cardiac survival were %VO(2) (RR = 3.76 [95% CI 2.19 to 6.45], p < 0.00001) and LAD (RR = 1.90 [95% CI 1.10 to 3.28], p = 0.02).	vo(2)	103-108	natriuretic peptide B	Homo sapiens	49-52
14625505-13	2003	In addition, RPE increased significantly from VO(2) 10% to VO(2) @ 4 mM and from VO(2) @ 4 mM to VO(2) 10% -; whereas FS demonstrated a slight decrease from VO(2) 10% to VO(2) @ 4 mM, and a more substantial and significant decrease from VO(2) @ 4 mM to VO(2) 10% -.	vo(2)	46-51	ribulose-5-phosphate-3-epimerase	Homo sapiens	13-16
14625505-13	2003	In addition, RPE increased significantly from VO(2) 10% to VO(2) @ 4 mM and from VO(2) @ 4 mM to VO(2) 10% -; whereas FS demonstrated a slight decrease from VO(2) 10% to VO(2) @ 4 mM, and a more substantial and significant decrease from VO(2) @ 4 mM to VO(2) 10% -.	vo(2)	59-64	ribulose-5-phosphate-3-epimerase	Homo sapiens	13-16
12900688-0	2003	CPX/D underestimates VO(2) in athletes compared with an automated Douglas bag system.	vo(2)	21-26	EBP cholestenol delta-isomerase	Homo sapiens	0-3
12664087-7	2003	An 8% decrease in VO(2) measurements was observed following ICV Agrp treatment on day 1.	vo(2)	18-23	agouti related neuropeptide	Rattus norvegicus	64-68
15888840-8	2005	RESULTS: In PPH patients, the percentage of predicted peak oxygen uptake (Vo(2)) correlated significantly with mean pulmonary artery pressure (mPAP) [r = - 0.59, p = 0.0007, n = 29].	vo(2)	74-79	phospholipid phosphatase 1	Mus musculus	143-147
15142837-10	2004	In P20 and P70 rats, the drop of Vo(2) in hypoxia (-31% in P70, P < 0.0001) was not observed in ATD rats.	vo(2)	33-38	heat shock protein family B (small) member 6	Rattus norvegicus	3-6
15159038-14	2004	In CHF, BNP levels were inversely correlated with peak VO(2), VO(2)-AT and LVEF.	vo(2)	55-60	natriuretic peptide B	Homo sapiens	8-11
12691845-6	2003	In addition, intracerebroventricular administration of orexin-A (100 pmol) elicited a significantly smaller VO(2) response in Arc-lesioned rats than that in sham-operated control rats.	vo(2)	108-113	hypocretin neuropeptide precursor	Rattus norvegicus	55-63
12204502-6	2002	RESULTS: In patients with chronic HF, BNP levels correlated with oxygen uptake (VO(2)), both at anaerobic threshold (VO(2)AT: r = -0.54, p < 0.001) and peak exercise (peak VO(2): r = -0.56, p < 0.001).	vo(2)	117-122	natriuretic peptide B	Homo sapiens	38-41
12204502-12	2002	Brain natriuretic peptide levels show a significant correlation with the impairment of VO(2) at peak exercise and anaerobic threshold.	vo(2)	87-92	natriuretic peptide B	Homo sapiens	0-25
11842067-7	2002	The improvement in VO(2) and function due to the P(50) increase demonstrates the importance of O(2) diffusion in this cardiac ischemia model.	vo(2)	19-24	Y-box-binding protein 1	Oryctolagus cuniculus	49-54
10801278-12	2000	During ANG II-receptor block, an average decrease in VO(2) in SHR was not significant.	vo(2)	53-58	angiogenin	Rattus norvegicus	7-10
10720450-5	2000	RESULTS: Cardiac output, heart performance, organ blood flow, as well as DO(2) and VO(2), increased significantly 2 h after CLP.	vo(2)	83-88	coactosin-like F-actin binding protein 1	Rattus norvegicus	124-127